| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RELI | Common Stock | Award | $0 | +82,534 | +12.38% | $0 | 89,201 | 21 Jan 2025 | Direct | F1 |
| transaction | RELI | Common Stock | Tax liability | -$14,426 | -7,373 | -8.27% | $1.96 | 81,828 | 04 Feb 2025 | Direct | F2 |
| transaction | RELI | Common Stock | Award | $0 | +16,250 | +19.86% | $0 | 98,078 | 05 Feb 2025 | Direct | F3 |
| transaction | RELI | Common Stock | Tax liability | -$14,305 | -7,603 | -7.75% | $1.88 | 90,475 | 07 Feb 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents the grant of shares of common stock, approved by the compensation committee, comprised solely of independent directors, of the issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The grant vests (i) with respect to 16,510 shares on January 27, 2025; and (ii) with respect to 16,506 shares on each of February 3, 2025, July 15, 2025, July 30, 2025 and August 15, 2025. |
| F2 | Represents the payment of tax liability by delivering securities incident to the receipt of the January 21, 2025 stock grant which was issued in accordance with Rule 16b-3 promulgated pursuant to the Exchange Act. This transaction is exempt from Section 16(b) of the Exchange Act. |
| F3 | Represents the grant of shares of common stock, approved by the compensation committee, comprised solely of independent directors, of the issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Exchange Act. The grant vests (i) with respect to 5,418 shares on August 30, 2025; and (ii) with respect to 5,416 on each of September 15, 2025, and September 30, 2025. |